Watch on-demand to ensure you’re equipped with the QC skills, technology and guidance needed to release safe cell and gene therapies. 

Cell and gene therapies are critical emerging treatment modalities with the potential to tackle and cure conditions from life-limiting genetic disorders to cancers. However, being novel, biological and potentially personalised presents a whole range of quality control challenges. During this conference expert speakers addressed the critical element of microbiological safety and control. 

Listen to leading cell and gene therapy quality control experts to discover how the industry is rapidly advancing ways to ensure microbiological QC testing can keep up with these complex therapies. 

Our line-up of industry leading speakers elaborate on the risks of inadequate microbial testing during the manufacture of cell and gene therapies, addressing how they can be mitigated to ensure patient safety. This event is for manufacturing and quality control personnel looking to: 

• Obtain an understanding of the critical technological advances that ensure future workflows will be faster and more efficient for endotoxin detection, microbial contamination detection and identification. 
• Learn from real-world case study examples on the benefits of sound environmental monitoring, in-process testing and rapid sterility, as well as how to troubleshoot challenges. 

Watch on-demand to hear from QC experts on best practices, and to explore technological advances that can support the efficient release of safe cell and gene therapies.